Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WuXi AppTec H | Hong Kong | Salute | Ricerca medica e biotecnologica | 177,45 Mrd HKD | 19,5x | -1,3 | 57,95 HKD | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,1% Rialzo | Fai l’upgrade a Pro+ | |
Hansoh Pharmaceutical Group | Hong Kong | Salute | Prodotti farmaceutici | 113,35 Mrd HKD | 25,7x | 0,29 | 18,60 HKD | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,9% Rialzo | Fai l’upgrade a Pro+ | |
WuXi Biologics | Hong Kong | Salute | Ricerca medica e biotecnologica | 74,95 Mrd HKD | 22,9x | -0,69 | 18,42 HKD | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -2,6% Ribasso | Fai l’upgrade a Pro+ | |
Sinopharm Group Co | Hong Kong | Salute | Prodotti farmaceutici | 66,16 Mrd HKD | 7,1x | -2,23 | 21,20 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,6% Rialzo | Fai l’upgrade a Pro+ | |
Innovent Biologics | Hong Kong | Salute | Prodotti farmaceutici | 62,49 Mrd HKD | -44,6x | -4,15 | 38,20 HKD | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 40,8% Rialzo | Fai l’upgrade a Pro+ | |
Sino Biopharmaceutical | Hong Kong | Salute | Prodotti farmaceutici | 61,17 Mrd HKD | 14,1x | 0,2 | 3,36 HKD | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,8% Rialzo | Fai l’upgrade a Pro+ | |
Tigermed | Hong Kong | Salute | Ricerca medica e biotecnologica | 60,18 Mrd HKD | 58,8x | -0,96 | 34,90 HKD | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,5% Rialzo | Fai l’upgrade a Pro+ | |
CSPC Pharma | Hong Kong | Salute | Prodotti farmaceutici | 58,13 Mrd HKD | 10,7x | -0,69 | 5,02 HKD | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 32,6% Rialzo | Fai l’upgrade a Pro+ | |
Akeso | Hong Kong | Salute | Ricerca medica e biotecnologica | 57,44 Mrd HKD | -74,9x | 0,54 | 63,25 HKD | -1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,9% Rialzo | Fai l’upgrade a Pro+ | |
Pharmaron Beijing Co Ltd | Hong Kong | Salute | Ricerca medica e biotecnologica | 56,12 Mrd HKD | 27,8x | 1,19 | 14,96 HKD | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 24,6% Rialzo | Fai l’upgrade a Pro+ | |
Shanghai Pharma Holding | Hong Kong | Salute | Prodotti farmaceutici | 49,12 Mrd HKD | 11,5x | -1,54 | 13,28 HKD | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,9% Rialzo | Fai l’upgrade a Pro+ | |
Sichuan Kelun Biotech | Hong Kong | Salute | Ricerca medica e biotecnologica | 41,05 Mrd HKD | -188x | -3,02 | 189,80 HKD | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,5% Rialzo | Fai l’upgrade a Pro+ | |
Shanghai Fosun Pharmaceutical | Hong Kong | Salute | Prodotti farmaceutici | 38,35 Mrd HKD | 17,2x | -0,72 | 14,50 HKD | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 22,5% Rialzo | Fai l’upgrade a Pro+ | |
WuXi XDC Cayman | Hong Kong | Salute | Prodotti farmaceutici | 37,74 Mrd HKD | 48,1x | 0,46 | 32 HKD | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 1,6% Rialzo | Fai l’upgrade a Pro+ | |
China Resources Pharma | Hong Kong | Salute | Prodotti farmaceutici | 33,61 Mrd HKD | 8,4x | 0,82 | 5,37 HKD | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 28,8% Rialzo | Fai l’upgrade a Pro+ | |
Asymchem Laboratories Tianjin | Hong Kong | Salute | Prodotti farmaceutici | 32,21 Mrd HKD | 39,3x | -0,53 | 54,90 HKD | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 35,1% Rialzo | Fai l’upgrade a Pro+ | |
Guangzhou Baiyunshan Pharma | Hong Kong | Salute | Prodotti farmaceutici | 29,52 Mrd HKD | 8,1x | -0,64 | 18,20 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,9% Rialzo | Fai l’upgrade a Pro+ | |
Livzon Pharma | Hong Kong | Salute | Prodotti farmaceutici | 25,03 Mrd HKD | 17,5x | 8,27 | 27,70 HKD | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 10,5% Rialzo | Fai l’upgrade a Pro+ | |
Genscript Biotech Corp | Hong Kong | Salute | Ricerca medica e biotecnologica | 22,78 Mrd HKD | -16,4x | -3,72 | 10,68 HKD | -5,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
HUTCHMED | Hong Kong | Salute | Prodotti farmaceutici | 22,62 Mrd HKD | -70,2x | 8,16 | 25,60 HKD | -3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 49,3% Rialzo | Fai l’upgrade a Pro+ | |
Shandong Weigao Medical Polymer | Hong Kong | Salute | Attrezzature e forniture medicali | 22,40 Mrd HKD | 10,9x | -0,51 | 4,94 HKD | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,8% Rialzo | Fai l’upgrade a Pro+ | |
Zai Lab | Hong Kong | Salute | Prodotti farmaceutici | 21,23 Mrd HKD | -9,7x | -0,92 | 21,65 HKD | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
United Laboratories Int | Hong Kong | Salute | Prodotti farmaceutici | 21,04 Mrd HKD | 6,8x | 0,22 | 11,58 HKD | 1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 4,5% Rialzo | Fai l’upgrade a Pro+ | |
Shenzhen Hepalink | Hong Kong | Salute | Prodotti farmaceutici | 18,25 Mrd HKD | -116,2x | 0,64 | 4,17 HKD | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -7,1% Ribasso | Fai l’upgrade a Pro+ | |
China Medical System | Hong Kong | Salute | Prodotti farmaceutici | 18,24 Mrd HKD | 12,5x | -0,22 | 7,58 HKD | -1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 31% Rialzo | Fai l’upgrade a Pro+ | |
Simcere | Hong Kong | Salute | Prodotti farmaceutici | 17,62 Mrd HKD | -14,4x | 0,11 | 7,05 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,9% Rialzo | Fai l’upgrade a Pro+ | |
Remegen | Hong Kong | Salute | Ricerca medica e biotecnologica | 16,68 Mrd HKD | -5,5x | 0,61 | 16,98 HKD | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 29,8% Rialzo | Fai l’upgrade a Pro+ | |
China Grand Pharma | Hong Kong | Salute | Prodotti farmaceutici | 16,21 Mrd HKD | 6,8x | 3,49 | 4,67 HKD | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,1% Rialzo | Fai l’upgrade a Pro+ | |
XtalPi Holdings | Hong Kong | Salute | Attrezzature e forniture medicali | 15,98 Mrd HKD | -2,6x | 3,96 HKD | -8,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
3SBio | Hong Kong | Salute | Prodotti farmaceutici | 14,53 Mrd HKD | 8,5x | -0,78 | 6,23 HKD | 1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 24,6% Rialzo | Fai l’upgrade a Pro+ |